Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will provide (a) funding and (b) resources to support a year-round online (i) HIV and (ii) STI postal testing service.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Scaling up HIV testing for all population groups will be a key objective of the new HIV Action Plan, which is due to be published in summer 2025. We are currently working together with the UK Health Security Agency, NHS England, and other key stakeholders and considering which testing interventions would be best suited to achieve our ambitions, including the most effective role for online testing.
On 28 November 2024, the Prime Minister confirmed £27 million of additional funding for 2025/26 to expand the highly successful National Health Service emergency department opt-out HIV testing programme, supporting national HIV testing. As part of the extension of the programme, approximately 90 sites will be offered funding to roll out HIV opt-out testing until March 2026. Further funding will be confirmed in due course after the spending review phase two process has concluded.
Local authorities in England are responsible for commissioning open access sexual health services, including HIV and sexually transmitted infection (STI) testing services, through the public health grant, funded at £3.6 billion in 2024/25. It is for individual local authorities to decide their spending priorities based on an assessment of local need, and to commission the services that best suit their population, including decisions about online, face to face or postal testing services. We have set up the national HIV and syphilis self-sampling framework to assist local authority commissioners with providing online testing to their residents.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to (a) measure and (b) ensure improvements in the quality of life of people living with HIV.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK Health and Security Agency (UKHSA) provides key surveillance and data for HIV, including annual official HIV statistics and reports. Their recently published HIV Action Plan Monitoring and Evaluation Framework 2024 report provides key indicators of the quality of life of people living with HIV, and recommendations for improvements to HIV care. The UKHSA also publishes the Positive Voices survey report periodically, updated recently in 2024, which includes questions on people’s lived experience and stigma. As part of the current HIV Action Plan, the Department funds HIV Prevention England, which hosted a HIV Stigma Symposium in March 2024. This brought together approximately 100 community experts, activists, healthcare professionals, and people with lived experience to discuss the impact of HIV stigma and explore effective stigma reduction strategies across the country. This evidence will inform the Government's new HIV Action Plan, which is due to be published in summer 2025. We will consider the key actions needed to support the groups disproportionately affected by HIV, to ensure improvements in the quality of life of all people living with HIV.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce levels of obesity in (a) Jarrow and Gateshead East constituency and (b) other constituencies with high rates of obesity; and if he will take steps to support dietitian-led weight management programmes in such areas.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Local authorities and the National Health Service provide weight management services to support their communities to achieve and maintain a healthier weight. These range from behavioural weight management programmes, to specialist services for those living with obesity and associated co-morbidities. Local authorities are able to spend funding from the Public Health Grant on behavioural weight management services, whilst integrated care boards (ICBs) are responsible for commissioning NHS specialist weight management services. Local authorities and ICBs should consider local population need and the relevant guidance when commissioning and designing services, including when considering how the service should be led or the intervention delivered.
The North East and North Cumbria ICB is developing its Healthy Weight and Treating Obesity strategy. Additionally, NHS England commissions the NHS Digital Weight Management Programme nationally for people living with obesity, with an existing comorbidity of either diabetes, hypertension, or both. The 12-week online programme is available to eligible people across England, including in the Jarrow and Gateshead East constituency, via direct referral from any general practice or Community Pharmacy.
The Government will take action to tackle the root causes of the obesity crisis head on, including through shifting the focus from treatment to prevention. We have made a strong start, including laying the necessary secondary legislation to implement the advertising restrictions for less healthy food or drink on television and online from 1 October 2025, taking steps to ensure the Soft Drinks Industry Levy remains effective and fit-for-purpose, and giving local authorities the stronger, clearer powers they have told us they need to block new fast food outlets near schools.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing additional funding for community-based health initiatives in (a) Jarrow and Gateshead East constituency and (b) other constituencies with high rates of obesity.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Local authorities and the National Health Service provide weight management services to support their communities to achieve and maintain a healthier weight. These range from behavioural weight management programmes, to specialist services for those living with obesity and associated co-morbidities. Local authorities are able to spend funding from the Public Health Grant on behavioural weight management services, whilst integrated care boards (ICBs) are responsible for commissioning NHS specialist weight management services. Local authorities and ICBs should consider local population need and the relevant guidance when commissioning and designing services, including when considering how the service should be led or the intervention delivered.
The North East and North Cumbria ICB is developing its Healthy Weight and Treating Obesity strategy. Additionally, NHS England commissions the NHS Digital Weight Management Programme nationally for people living with obesity, with an existing comorbidity of either diabetes, hypertension, or both. The 12-week online programme is available to eligible people across England, including in the Jarrow and Gateshead East constituency, via direct referral from any general practice or Community Pharmacy.
The Government will take action to tackle the root causes of the obesity crisis head on, including through shifting the focus from treatment to prevention. We have made a strong start, including laying the necessary secondary legislation to implement the advertising restrictions for less healthy food or drink on television and online from 1 October 2025, taking steps to ensure the Soft Drinks Industry Levy remains effective and fit-for-purpose, and giving local authorities the stronger, clearer powers they have told us they need to block new fast food outlets near schools.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to integrate HIV (a) prevention and (b) care into the broader health system.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
HIV is a priority for the Government, and we have commissioned a new HIV Action Plan to end new HIV transmissions within England by 2030. Integration of services and strengthening the delivery of HIV prevention and care will be key objectives of the plan, which we aim to publish in summer 2025.
The voluntary and community sector (VCS) has been a key partner in the development and implementation of the existing HIV Action Plan, and will continue to be a key partner in the new plan. The Terrence Higgins Trust, the Elton John AIDS Foundation, and the National AIDS Trust have led engagement with the VCS and the wider community to develop recommendations for the new plan, including relating to culturally competent interventions. These were published on 25 November and will be considered in the development of the new HIV Action Plan.
In addition, as part of its HIV Prevention England programme, the Department will host three further engagement sessions with the VCS during February and March 2025, including patients with lived experience.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what role the voluntary sector will play in the new HIV Action Plan; and what steps he will take to support that role.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
HIV is a priority for the Government, and we have commissioned a new HIV Action Plan to end new HIV transmissions within England by 2030. Integration of services and strengthening the delivery of HIV prevention and care will be key objectives of the plan, which we aim to publish in summer 2025.
The voluntary and community sector (VCS) has been a key partner in the development and implementation of the existing HIV Action Plan, and will continue to be a key partner in the new plan. The Terrence Higgins Trust, the Elton John AIDS Foundation, and the National AIDS Trust have led engagement with the VCS and the wider community to develop recommendations for the new plan, including relating to culturally competent interventions. These were published on 25 November and will be considered in the development of the new HIV Action Plan.
In addition, as part of its HIV Prevention England programme, the Department will host three further engagement sessions with the VCS during February and March 2025, including patients with lived experience.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will ensure that the new HIV Action Plan includes culturally competent interventions.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
HIV is a priority for the Government, and we have commissioned a new HIV Action Plan to end new HIV transmissions within England by 2030. Integration of services and strengthening the delivery of HIV prevention and care will be key objectives of the plan, which we aim to publish in summer 2025.
The voluntary and community sector (VCS) has been a key partner in the development and implementation of the existing HIV Action Plan, and will continue to be a key partner in the new plan. The Terrence Higgins Trust, the Elton John AIDS Foundation, and the National AIDS Trust have led engagement with the VCS and the wider community to develop recommendations for the new plan, including relating to culturally competent interventions. These were published on 25 November and will be considered in the development of the new HIV Action Plan.
In addition, as part of its HIV Prevention England programme, the Department will host three further engagement sessions with the VCS during February and March 2025, including patients with lived experience.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to stop young sudden cardiac deaths; and if he will make an assessment of the potential merits of (a) increasing the availability of ECG testing for young people and (b) ensuring doctors are sufficiently trained to interpret ECGs in fit and active young people.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK National Screening Committee does not recommend offering screening for sudden cardiac death (SCD) in people under the age of 39 years old. Research showed that current tests are not accurate enough to use in young people without symptoms. Individuals with the condition may receive a negative test result, a false negative, giving them false reassurance.
Doctors are already trained to interpret electrocardiograms in fit and active young people. To stop young SCDs, the consensus is to focus on rapid identification and care of people who are likely to be at risk of SCD, due to a family link or because they have had symptoms, and to train people to carry out cardiopulmonary resuscitation and to use defibrillators.
NHS England has published guidance for inherited cardiac conditions, which requires services to investigate patients with previously undiagnosed cardiac disease, suggestive symptoms, or from families with sudden unexplained deaths. Where a genetic variation is identified, cascade testing is offered to relatives based on risk.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that people who require enzyme replacement therapy receive that medication in a timely manner.
Answered by Andrew Stephenson
We are aware of the supply issues with the three enzyme replacement therapies, Creon 10,000 gastro-resistant capsules, Creon 25,000 gastro-resistant capsules, and Nutrizym 22 capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The Department will be issuing updated guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to help drive the resolution of these issues as quickly as possible, for example by expediting orders and increasing forecasts. We are also working with specialist importers to source unlicensed imports from abroad.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.
Asked by: Kate Osborne (Labour - Jarrow and Gateshead East)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with pharmaceutical companies on ensuring adequate supplies of (a) enzyme replacement therapy and (b) other related medications.
Answered by Andrew Stephenson
We are aware of the supply issues with the three enzyme replacement therapies, Creon 10,000 gastro-resistant capsules, Creon 25,000 gastro-resistant capsules, and Nutrizym 22 capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The Department will be issuing updated guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to help drive the resolution of these issues as quickly as possible, for example by expediting orders and increasing forecasts. We are also working with specialist importers to source unlicensed imports from abroad.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.